Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ACON is expected to report earnings to fall 96.88% to -9 cents per share on November 29
Q3'23
Est.
$-0.09
Q2'23
Missed
by $2.79
Q1'23
Est.
$-0.10
Q4'22
Est.
$-0.17
Q3'22
Missed
by $3.15
The last earnings report on August 25 showed earnings per share of -288 cents, missing the estimate of -9 cents. With 17.85K shares outstanding, the current market capitalization sits at 2.93M.